You may also like
Total Artificial Heart in the Pediatric Patient with Biventricular Heart Failure
SynCardia Systems, Inc. recommends a minimum patient body surface area (BSA) of 1.7 m2, thus, limiting pediatric application of this device
Use of Bivalirudin in Pediatric Cardiac ECMO with Concomitant Plasmapheresis Treatment (EP Video)
Daniel Gomez presents a case report on the use of Bivalirudin in pediatric cardiac ECMO with concomitant plasmapheresis (20:03 minutes).
Hybrid Extracorporeal Membrane Oxygenation
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) therapy is widely used in critically ill patients with refractory cardiogenic shock and cardiac arrest or suffering from severe respiratory failure. Besides traditional ECMO cannulation, changes in patients' conditions or the occurrence of specific complications (i.e., cerebral hypoxia or left ventricular dilation) may require modifications in cannulation strategies or the combination of ECMO with additional invasive or minimally invasive procedures, to improve organ function and ECMO efficiency.
